Suppr超能文献

胃癌发生的分子机制。

Molecular mechanism of stomach carcinogenesis.

作者信息

Tahara E

出版信息

J Cancer Res Clin Oncol. 1993;119(5):265-72. doi: 10.1007/BF01212724.

Abstract

Gene changes in multiple oncogenes, multiple growth factors and multiple tumor-suppressor genes are observed in stomach cancer. Among them, those most commonly implicated in both well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma are inactivation (mutations and allele loss) of the p53 gene, and activation (abnormal expression and amplification) of the c-met gene. Moreover, they occur at an early stage of stomach carcinogenesis. In addition, loss of heterozygosity (LOH) on chromosome 5q (APC locus) is frequently associated with well-differentiated adenocarcinoma. LOH on chromosome 18q (DCC locus) and LOH of the bcl-2 gene also are common events of well-differentiated adenocarcinoma. LOH on chromosomes 1q and 7q may be involved in the progression of well-differentiated adenocarcinoma. Conversely, the development of poorly differentiated adenocarcinoma, in addition to changes in p53 and c-met genes, requires reduction or dysfunction of cadherin. Overexpression of bcl-2 protein is observed in poorly differentiated adenocarcinoma or signet-ring cell carcinoma. Moreover, the K-sam gene is amplified preferentially in poorly differentiated adenocarcinoma of scirrhous carcinoma. K-sam amplification in scirrhous carcinoma often occurs independently of c-met gene amplification. LOH on chromosome 1p also is relatively common in poorly differentiated adenocarcinoma. Exceptionally, signet-ring cell carcinoma shares APC mutations. There are some differences in expression of the growth-factor/receptor system between well-differentiated adenocarcinoma and poorly differentiated adenocarcinoma. Moreover, interaction between cell-adhesion molecules in tumor cells expressing c-met and hepatocyte growth factor (HGF) from stromal cells is linked with morphogenesis of two histological types of stomach cancer. Intestinal metaplasia and adenoma of the stomach also contain p53 mutations and K-ras mutations or tpr-met rearrangement. Taken together, different genetic pathways of stomach carcinogenesis may exist for poorly differentiated and well-differentiated stomach cancers. Some of the latter may develop by a cumulative series of gene alterations similar to those of colorectal cancer.

摘要

在胃癌中可观察到多个癌基因、多种生长因子和多个肿瘤抑制基因发生改变。其中,在高分化腺癌和低分化腺癌中最常涉及的是p53基因的失活(突变和等位基因缺失)以及c-met基因的激活(异常表达和扩增)。此外,它们发生在胃癌发生的早期阶段。另外,5号染色体q臂(APC位点)的杂合性缺失(LOH)常与高分化腺癌相关。18号染色体q臂(DCC位点)的LOH以及bcl-2基因的LOH也是高分化腺癌的常见事件。1号和7号染色体的LOH可能参与高分化腺癌的进展。相反,低分化腺癌的发生,除了p53和c-met基因的改变外,还需要钙黏蛋白减少或功能障碍。在低分化腺癌或印戒细胞癌中可观察到bcl-2蛋白的过表达。此外,K-sam基因在硬癌的低分化腺癌中优先扩增。硬癌中的K-sam扩增常独立于c-met基因扩增发生。1号染色体的LOH在低分化腺癌中也相对常见。特别的是,印戒细胞癌存在APC突变。高分化腺癌和低分化腺癌之间在生长因子/受体系统的表达上存在一些差异。此外,表达c-met的肿瘤细胞中的细胞黏附分子与基质细胞中的肝细胞生长因子(HGF)之间的相互作用与两种组织学类型胃癌的形态发生有关。胃的肠化生和腺瘤也含有p53突变、K-ras突变或tpr-met重排。综上所述,高分化和低分化胃癌可能存在不同的胃癌发生遗传途径。后者中的一些可能通过一系列类似于结直肠癌的累积基因改变而发生。

相似文献

1
Molecular mechanism of stomach carcinogenesis.胃癌发生的分子机制。
J Cancer Res Clin Oncol. 1993;119(5):265-72. doi: 10.1007/BF01212724.
4
Molecular biology of gastric cancer.胃癌的分子生物学
World J Surg. 1995 Jul-Aug;19(4):484-8; discussion 489-90. doi: 10.1007/BF00294705.
6
[Multistep stomach carcinogenesis].
Nihon Rinsho. 1996 Apr;54(4):1066-71.

引用本文的文献

2
Therapeutic strategy for scirrhous type gastric cancer.硬癌型胃癌的治疗策略
Jpn J Clin Oncol. 2025 Aug 3;55(8):860-870. doi: 10.1093/jjco/hyaf081.
8
Protein kinase Cι is a new prognostic factor in gastric cancer.
Surg Today. 2015 Jun;45(6):759-64. doi: 10.1007/s00595-014-1010-5. Epub 2014 Aug 10.

本文引用的文献

1
Genetic abnormalities and expression of p53 in human colon carcinomas.
Int J Oncol. 1992 Sep;1(4):431-7. doi: 10.3892/ijo.1.4.431.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验